Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer treatments may improve heart function and reduce fibrosis without requiring tumor growth. Less aggressive cancer cells and mouse embryo fibroblasts (MEF) showed beneficial effects on cardiac dysfunction and fibrosis in MDX mice.
Area Of Science
- Cardiovascular Biology
- Oncology
- Fibrosis Research
Background
- The interplay between heart failure and cancer is complex, with bidirectional influences.
- Cardiac remodeling can promote cancer progression, while tumors may paradoxically improve cardiac function and reduce fibrosis.
- The underlying mechanisms of cancer's impact on cardiac fibrosis remain unclear.
Purpose Of The Study
- To investigate the mechanisms by which cancer influences cardiac fibrosis and dysfunction.
- To determine if cancer cell aggressiveness impacts the observed beneficial effects on cardiac health.
- To explore potential therapeutic strategies for fibrotic heart disease independent of tumor formation.
Main Methods
- Utilized the MDX mouse model, characterized by cardiac fibrosis and dysfunction.
- Administered aggressive (PyMT, LLC) and less aggressive (integrin β1 KO PyMT) breast cancer cell lines.
- Introduced Mouse Embryo Fibroblasts (MEF) cells to assess their impact on cardiac parameters.
Main Results
- Tumor growth from aggressive and less aggressive cancer cell lines improved cardiac function and reduced fibrosis in MDX mice.
- Injection of integrin β1 knockout PyMT cells and MEF cells ameliorated cardiac dysfunction and fibrosis.
- Both cancer cell line aggressiveness and MEF cells were sufficient to induce beneficial cardiac phenotypes.
Conclusions
- Cancer cell aggressiveness and even non-tumorigenic cells like MEFs can confer protective effects against cardiac fibrosis and dysfunction.
- These findings suggest novel therapeutic avenues for fibrotic heart diseases and cardiac dysfunction, potentially bypassing the need for tumor growth.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
